Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.52M Sell
14,477
-904
-6% -$84.9K 0.6% 41
2025
Q3
$1.29M Sell
15,381
-1,442
-9% -$119K 0.58% 40
2025
Q2
$1.33M Sell
16,823
-100
-0.6% -$7.95K 0.63% 40
2025
Q1
$1.52M Buy
16,923
+2,822
+20% +$263K 0.75% 35
2024
Q4
$1.4M Buy
14,101
+617
+5% +$63.6K 0.64% 36
2024
Q3
$1.53M Buy
13,484
+1,250
+10% +$149K 0.72% 34
2024
Q2
$1.51M Sell
12,234
-172
-1% -$22.2K 0.76% 30
2024
Q1
$1.64M Buy
+12,406
New +$1.53M 0.87% 30

Other funds holding MRK

Ransom Advisory's MRK Position: Q4 2025 in Review

Ransom Advisory reduced its Merck (MRK) stake by 5.9% in Q4 2025, selling an estimated $84.9K and leaving 14,477 shares worth $1.52M. The position accounts for 0.6% of the portfolio, ranked #41.

Ransom Advisory first reported a position in MRK in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.64M in Q1 2024. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Ransom Advisory held 14,477 shares of Merck worth $1.52M as of Q4 2025.
  • Ransom Advisory sold 904 Merck shares in Q4 2025, an estimated $84.9K.
  • Merck made up 0.6% of Ransom Advisory's portfolio in Q4 2025, its #41 holding.
  • Ransom Advisory first reported a position in Merck in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Merck position peaked at $1.64M in Q1 2024.
  • 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.